This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Emery, C. L. Articles by Weymouth, L. A. Search for Related Content PubMed PubMed Citation Articles by Emery, C. L. Articles by Weymouth, L. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 08 1997, 2061-2067, Vol 35, No. 8
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Detection and clinical significance of extended-spectrum beta- lactamases in a tertiary-care medical center

CL Emery and LA Weymouth
Department of Pathology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.

The prevalence of extended-spectrum beta-lactamase (ESBL)-mediated resistance remains unknown for most hospitals, and national guidelines for testing and reporting ESBL-mediated resistance have not yet been developed. We undertook a study to determine the prevalence of ESBLs and the clinical need for testing in our tertiary-care medical center. Members of the family Enterobacteriaceae isolated over a 6-month period for which ceftazidime or ceftriaxone MICs were greater than 1 microg/ml were tested for production of ESBLs by the double-disk synergy method. Approximately 1.5% of isolates of the family Enterobacteriaceae (50 of 3,273), which were isolated from 1.2% of patients (23 of 1,844), were found to express ESBLs. ESBL-producing strains included eight different species and were isolated from patients located throughout the hospital, including outpatient clinics. By using the interpretive guidelines of the National Committee for Clinical Laboratory Standards, 26 to 39% of the isolates would have been reported to be susceptible to ceftazidime, depending upon the routine susceptibility method used. However, tests with cefpodoxime found all of the ESBL-producing strains to be resistant or intermediate. Nine patients infected with ESBL- producing isolates were treated with therapy which included an expanded- spectrum cephalosporin. Seven were cured. The deaths of the other two patients were not attributed to bacterial resistance missed by routine susceptibility testing. These observations suggest that in our tertiary- care medical center, it may not be clinically necessary or cost- effective at this time to institute additional testing on a routine basis to detect ESBL production in all clinical isolates of the family Enterobacteriaceae.

This article has been cited by other articles:

• Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y., on behalf of ReAct-Action on Antibiotic Resistance, (2008). Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli. Antimicrob. Agents Chemother. 52: 813-821 [Full Text]  
• Peralta, G., Sanchez, M. B., Garrido, J. C., De Benito, I., Cano, M. E., Martinez-Martinez, L., Roiz, M. P. (2007). Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 60: 855-863 [Abstract] [Full Text]  
• See, K. C., Than, H. A., Tang, T. (2007). Enterobacter sakazakii bacteraemia with multiple splenic abscesses in a 75-year-old woman: a case report. Age Ageing 36: 595-596 [Abstract] [Full Text]  
• Yang, K., Guglielmo, B J. (2007). Diagnosis and Treatment of Extended-Spectrum and AmpC {beta}-Lactamase-Producing Organisms. The Annals of Pharmacotherapy 41: 1427-1435 [Abstract] [Full Text]  
• Kim, H., Ryu, J.-H., Beuchat, L. R. (2006). Attachment of and Biofilm Formation by Enterobacter sakazakii on Stainless Steel and Enteral Feeding Tubes. Appl. Environ. Microbiol. 72: 5846-5856 [Abstract] [Full Text]  
• Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
• Linscott, A. J., Brown, W. J. (2005). Evaluation of Four Commercially Available Extended-Spectrum Beta-Lactamase Phenotypic Confirmation Tests. J. Clin. Microbiol. 43: 1081-1085 [Abstract] [Full Text]  
• Jiang, X., Ni, Y., Jiang, Y., Yuan, F., Han, L., Li, M., Liu, H., Yang, L., Lu, Y. (2005). Outbreak of Infection Caused by Enterobacter cloacae Producing the Novel VEB-3 Beta-Lactamase in China. J. Clin. Microbiol. 43: 826-831 [Abstract] [Full Text]  
• Aibinu, I. E., Ohaegbulam, V. C., Adenipekun, E. A., Ogunsola, F. T., Odugbemi, T. O., Mee, B. J. (2003). Extended-Spectrum {beta}-Lactamase Enzymes in Clinical Isolates of Enterobacter Species from Lagos, Nigeria. J. Clin. Microbiol. 41: 2197-2200 [Abstract] [Full Text]  
• Jain, A., Roy, I., Gupta, M. K., Kumar, M., Agarwal, S. K. (2003). Prevalence of extended-spectrum {beta}-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 52: 421-425 [Abstract] [Full Text]  
• Pepperell, C., Kus, J. V., Gardam, M. A., Humar, A., Burrows, L. L. (2002). Low-Virulence Citrobacter Species Encode Resistance to Multiple Antimicrobials. Antimicrob. Agents Chemother. 46: 3555-3560 [Abstract] [Full Text]  
• Spanu, T., Luzzaro, F., Perilli, M., Amicosante, G., Toniolo, A., Fadda, G. (2002). Occurrence of Extended-Spectrum {beta}-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to {beta}-Lactams and Other Antimicrobial Drugs. Antimicrob. Agents Chemother. 46: 196-202 [Abstract] [Full Text]  
• Bradford, P. A. (2001). Extended-Spectrum {beta}-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat. Clin. Microbiol. Rev. 14: 933-951 [Abstract] [Full Text]  
• Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., Yu, V. L. (2001). Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum {beta}-Lactamases: Implications for the Clinical Microbiology Laboratory. J. Clin. Microbiol. 39: 2206-2212 [Abstract] [Full Text]  
• Fung, H. B., Kuczynski, S., Finch, D. A., Ramos, L. (2001). Current Issues in Gram-Negative Resistance: Extended-Spectrum Beta-Lactamases and Inducible Beta-Lactamases. Journal of Pharmacy Practice 14: 6-17 [Abstract]  
• Tzelepi, E., Giakkoupi, P., Sofianou, D., Loukova, V., Kemeroglou, A., Tsakris, A. (2000). Detection of Extended-Spectrum beta -Lactamases in Clinical Isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 38: 542-546 [Abstract] [Full Text]  
• Tenover, F. C., Mohammed, M. J., Gorton, T. S., Dembek, Z. F. (1999). Detection and Reporting of Organisms Producing Extended-Spectrum beta -Lactamases: Survey of Laboratories in Connecticut. J. Clin. Microbiol. 37: 4065-4070 [Abstract] [Full Text]  
• Wiener, J., Quinn, J. P., Bradford, P. A., Goering, R. V., Nathan, C., Bush, K., Weinstein, R. A. (1999). Multiple Antibiotic-Resistant Klebsiella and Escherichia coli in Nursing Homes. JAMA 281: 517-523 [Abstract] [Full Text]  
• Liu, P. Y.-F., Tung, J.-C., Ke, S.-C., Chen, S.-L. (1998). Molecular Epidemiology of Extended-Spectrum beta -Lactamase-Producing Klebsiella pneumoniae Isolates in a District Hospital in Taiwan. J. Clin. Microbiol. 36: 2759-2762 [Abstract] [Full Text]